MLNT
Melinta Therapeutics, Inc. Common Stock
MLNT
MLNT
Delisted
MLNT was delisted on the 10th of January, 2020.
87 hedge funds and large institutions have $246M invested in Melinta Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 13 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less call options, than puts
Call options by funds: $695K | Put options by funds: $706K
Holders
87
Holding in Top 10
1
Calls
$695K
Puts
$706K
Top Buyers
| 1 | +$50M | |
| 2 | +$29.5M | |
| 3 | +$7.62M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.54M |
| 5 |
DM
Deerfield Management
New York
|
+$5.51M |
Top Sellers
| 1 | -$1.14M | |
| 2 | -$335K | |
| 3 | -$214K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$186K |
| 5 |
SDIC
South Dakota Investment Council
Sioux Falls,
South Dakota
|
-$158K |